Topics

G Protein Coupled Bile Acid Receptor 1 Pipeline Review, H2 2019 [Published by Global Markets Direct] Prices from USD $3080

05:14 EST 4 Dec 2019 | BioPortfolio Reports

G Protein Coupled Bile Acid Receptor 1 Pipeline Review, H2 2019


Summary


According to the recently published report 'G Protein Coupled Bile Acid Receptor 1 Pipeline Review, H2 2019'; G Protein Coupled Bile Acid Receptor 1 G Protein Coupled Receptor GPCR19 or Membrane Type Receptor For Bile Acids or hBG37 or GPR131 or GPBAR1 pipeline Target constitutes close to 7 molecules. Out of which approximately 5 molecules are developed by companies and remaining by the universities/institutes.


G Protein Coupled Bile Acid Receptor 1 G Protein Coupled Receptor GPCR19 or Membrane Type Receptor For Bile Acids or hBG37 or GPR131 or GPBAR1 G proteincoupled bile acid receptor 1 GPBAR1 is a protein encoded by the GPBAR1 gene. It is a receptor for bile acid. Bile acidbinding induces its internalization, activation of extracellular signalregulated kinase and intracellular cAMP production. It is involved in the suppression of macrophage functions by bile acids.


The report 'G Protein Coupled Bile Acid Receptor 1 Pipeline Review, H2 2019' outlays comprehensive information on the G Protein Coupled Bile Acid Receptor 1 G Protein Coupled Receptor GPCR19 or Membrane Type Receptor For Bile Acids or hBG37 or GPR131 or GPBAR1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action MoA, route of administration RoA and molecule type; that are being developed by Companies / Universities.


It also reviews key players involved in G Protein Coupled Bile Acid Receptor 1 G Protein Coupled Receptor GPCR19 or Membrane Type Receptor For Bile Acids or hBG37 or GPR131 or GPBAR1 targeted therapeutics development with respective active and dormant or discontinued projects. Currently, The molecules developed by companies in Phase II and Preclinical stages are 1 and 4 respectively. Similarly, the universities portfolio in Preclinical stages comprises 2 molecules, respectively. Report covers products from therapy areas Metabolic Disorders, Dermatology, Gastrointestinal and Undisclosed which include indications Type 2 Diabetes, Atopic Dermatitis Atopic Eczema, Metabolic Syndrome, Obesity, Ulcerative Colitis and Unspecified.


Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.


Scope


The report provides a snapshot of the global therapeutic landscape for G Protein Coupled Bile Acid Receptor 1 G Protein Coupled Receptor GPCR19 or Membrane Type Receptor For Bile Acids or hBG37 or GPR131 or GPBAR1

The report reviews G Protein Coupled Bile Acid Receptor 1 G Protein Coupled Receptor GPCR19 or Membrane Type Receptor For Bile Acids or hBG37 or GPR131 or GPBAR1 targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industryspecific sources

The report covers pipeline products based on various stages of development ranging from preregistration till discovery and undisclosed stages

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, RD brief, licensing and collaboration details other developmental activities

The report reviews key players involved in G Protein Coupled Bile Acid Receptor 1 G Protein Coupled Receptor GPCR19 or Membrane Type Receptor For Bile Acids or hBG37 or GPR131 or GPBAR1 targeted therapeutics and enlists all their major and minor projects

The report assesses G Protein Coupled Bile Acid Receptor 1 G Protein Coupled Receptor GPCR19 or Membrane Type Receptor For Bile Acids or hBG37 or GPR131 or GPBAR1 targeted therapeutics based on mechanism of action MoA, route of administration RoA and molecule type

The report summarizes all the dormant and discontinued pipeline projects

The report reviews latest news and deals related to G Protein Coupled Bile Acid Receptor 1 G Protein Coupled Receptor GPCR19 or Membrane Type Receptor For Bile Acids or hBG37 or GPR131 or GPBAR1 targeted therapeutics


Reasons to buy


Gain strategically significant competitor information, analysis, and insights to formulate effective RD strategies

Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage

Identify and understand the targeted therapy areas and indications for G Protein Coupled Bile Acid Receptor 1 G Protein Coupled Receptor GPCR19 or Membrane Type Receptor For Bile Acids or hBG37 or GPR131 or GPBAR1

Identify the use of drugs for target identification and drug repurposing

Identify potential new clients or partners in the target demographic

Develop strategic initiatives by understanding the focus areas of leading companies

Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding G Protein Coupled Bile Acid Receptor 1 G Protein Coupled Receptor GPCR19 or Membrane Type Receptor For Bile Acids or hBG37 or GPR131 or GPBAR1 development landscape

Develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Original Article: G Protein Coupled Bile Acid Receptor 1 Pipeline Review, H2 2019 [Published by Global Markets Direct] Prices from USD $3080

NEXT ARTICLE

More From BioPortfolio on "G Protein Coupled Bile Acid Receptor 1 Pipeline Review, H2 2019 [Published by Global Markets Direct] Prices from USD $3080"

Quick Search

Relevant Topics

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...